Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways

NCT ID: NCT01161056

Last Updated: 2015-09-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-05-31

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to enrol generally healthy adults, who are asked to provide a blood sample, to study how the immune system works.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary purpose of this research is to develop a better understanding of how the immune system works. By studying immune function in many people, we will be able to determine the range of normal variation.

The second purpose is to enroll people who are willing to serve as comparisons in future research studies into the Genotype and Phenotype Research Registry (GAP Registry).

Volunteers are asked to provide information on age, ethnicity and medical history. Volunteers are asked to provide a blood sample of up to 100cc and allow us to contact you about additional studies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Immune System Diseases

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Control Group

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over age 18
* Generally healthy

Exclusion Criteria

* History of autoimmune disease
* History of chronic immunodeficiency or chronic viral infections such as Epstein Barr virus, hepatitis or HIV
* Currently undergoing treatment for cancer
* Current treatment with immuno-suppressant drugs
* Pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

Sponsor Role collaborator

University of Alabama at Birmingham

OTHER

Sponsor Role collaborator

Northwell Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Peter Gregersen

Center Head

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Gregersen, MD

Role: PRINCIPAL_INVESTIGATOR

Northwell Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Feinstein Institute for Medical Research

Manhasset, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1RC2AR059092-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

09-081A

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lupus Genetics Studies
NCT00071175 COMPLETED
Genetics of Uveitis
NCT02357238 RECRUITING
Acute Pain Genomic Study
NCT01557751 COMPLETED NA